What is Atlantic Apothecary?
Atlantic Apothecary operates as a specialized pharmacy provider, distinguishing itself through a commitment to high-touch patient relationships and comprehensive medication education. The company offers a sophisticated suite of services, including pharmaceutical compounding, immunizations, and medication therapy management. By focusing on personalized medication packaging and disease state management, the firm addresses the critical needs of individuals requiring nuanced health resources. Its strategic presence in Smyrna and Camden, DE, allows the company to serve as a vital community health hub, bridging the gap between traditional pharmacy services and modern, patient-centric care models.
How much funding has Atlantic Apothecary raised?
Atlantic Apothecary has raised a total of $177K across 1 funding round:
Debt
$177K
Debt (2021): $177K with participation from PPP
Key Investors in Atlantic Apothecary
PPP
Public-Private Partnership
What's next for Atlantic Apothecary?
With the infusion of this latest capital, Atlantic Apothecary is well-positioned to scale its infrastructure and deepen its impact on community health outcomes. The strategic focus will likely shift toward expanding its medication therapy management programs and potentially integrating advanced digital health tools to streamline patient engagement. As the company navigates this late-stage growth phase, the emphasis remains on maintaining the high standard of personalized care that has become its hallmark. Future initiatives may include the optimization of its compounding facilities and the broadening of its immunization outreach, ensuring that the firm remains a cornerstone of health resources for its target demographic.
See full Atlantic Apothecary company page
